INVO Fertility, Inc. Proceeds from Notes Payable
INVO Fertility, Inc. (IVF) reported Proceeds from Notes Payable of $1.34 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2025-11-17
- INVO Fertility, Inc. proceeds from notes payable for the quarter ending 2024-12-31 was $650.00K.
- INVO Fertility, Inc. proceeds from notes payable for the quarter ending 2024-09-30 was $251.75K, a 89.27% decline year-over-year.
- INVO Fertility, Inc. proceeds from notes payable for the quarter ending 2024-06-30 was $217.50K.
- INVO Fertility, Inc. proceeds from notes payable for the quarter ending 2024-03-31 was $225.00K, a 68.49% decline year-over-year.
- INVO Fertility, Inc. proceeds from notes payable for fiscal 2024 was $1.34M, a 56.07% decline from fiscal 2023.
- INVO Fertility, Inc. proceeds from notes payable for fiscal 2023 was $3.06M, a 2960.25% increase from fiscal 2022.
- INVO Fertility, Inc. proceeds from notes payable for fiscal 2022 was $100.00K.
- INVO Fertility, Inc. proceeds from notes payable for fiscal 2020 was $157.62K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 9 month as first filed | Proceeds from Notes Payable 12 month | Proceeds from Notes Payable 12 month as first filed | Proceeds from Notes Payable 54 month | Proceeds from Notes Payable 57 month |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $650.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-30 | $901.75K derived: sum of 2 quarters · filed 2025-11-17 | $1.12M derived: sum of 3 quarters · filed 2025-11-17 | $1.34M 10-K · filed 2025-04-30 | ||||
| 2024-09-30 | $251.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $469.25K derived: sum of 2 quarters · filed 2025-11-17 | $694.25K 10-Q · filed 2025-11-17 | $694.25K derived: sum of 4 quarters · filed 2025-11-17 | ||||
| 2024-06-30 | $217.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $442.50K 10-Q · filed 2025-08-14 | $442.50K derived: sum of 3 quarters · filed 2025-08-14 | $2.79M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $225.00K 10-Q · filed 2025-05-20 | $225.00K derived: sum of 2 quarters · filed 2025-05-20 | $2.57M derived: sum of 3 quarters · filed 2025-05-20 | $2.57M derived: sum of 4 quarters · filed 2025-05-20 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-30 | $2.35M derived: sum of 2 quarters · filed 2025-04-30 | $2.35M derived: sum of 3 quarters · filed 2025-04-30 | $3.06M 10-K · filed 2025-04-30 | ||||
| 2023-09-30 | $2.35M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-19 | $2.35M derived: sum of 2 quarters · filed 2024-11-19 | $3.06M 10-Q · filed 2024-11-19 | |||||
| 2023-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2024-11-19 | $714.00K 10-Q/A · filed 2024-11-19 | ||||||
| 2023-03-31 | $714.00K 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | $100.00K 10-K/A · filed 2024-11-19 | |||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$2.49M derived: sum of 2 quarters · filed 2022-03-31 | $157.62K 10-K · filed 2022-03-31 | $3.00M 10-K · filed 2021-03-30 | ||||
| 2020-09-30 | -$2.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $157.62K 10-Q · filed 2021-11-15 | $3.00M 10-Q · filed 2020-11-16 | |||||
| 2020-06-30 | $2.64M 10-Q · filed 2021-08-16 | |||||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $0.00 derived: sum of 2 quarters · filed 2021-03-30 | $0.00 10-K · filed 2021-03-30 | |||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | ||||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-13 | |||||||
| 2011-09-30 | $2.88K derived: 10-Q 57 month − 10-Q 54 month · filed 2011-11-21 | $52.88K 10-Q · filed 2011-11-21 | ||||||
| 2011-06-30 | $50.00K 10-Q · filed 2011-08-22 | |||||||
| 2010-06-30 | $2.88K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |